To view this email as a web page, click here.
 
HIGHLIGHTS   |  May 17, 2019
 
ASCO: Assessing Low-Dose Chemo in Older, Frail Patients With Gastroesophageal Cancer
Researchers assessed outcomes with different chemo regimen doses in elderly or frail patients with gastroesophageal cancer, in this study presented ahead of the ASCO Annual Meeting.
Read more
 
Exercise Proves Beneficial for Breast Cancer Survivors, Yet Again
The results of a new study add to the list of benefits seen with exercise among breast cancer survivors: reducing the risk of cardiovascular disease.
Read more
ADVERTISEMENT
Advertisement
 
IN CASE YOU MISSED IT
 
Phase III SIERRA Trial Finds Iomab-B Promising for Relapsed/Refractory AML
Researchers are evaluating Iodine (131I) apamistamab plus HCT vs conventional care in older patients with active relapsed/refractory acute myeloid leukemia.
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.